Page last updated: 2024-08-26

mci 9038 and Hematologic Malignancies

mci 9038 has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Lai, CMB; Lee, AYY; Smith, T	1

Other Studies

1 other study(ies) available for mci 9038 and Hematologic Malignancies

Article	Year
Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series. Journal of thrombosis and thrombolysis, 2021, Volume: 51, Issue:3 Topics: Aged; Anticoagulants; Arginine; Canada; Female; Fondaparinux; Gastrointestinal Neoplasms; Hematologic Neoplasms; Hemorrhage; Heparin; Humans; Male; Patient Acuity; Pipecolic Acids; Platelet Count; Retrospective Studies; Risk Adjustment; Sulfonamides; Thrombocytopenia	2021

Article

Year

Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series.

Journal of thrombosis and thrombolysis, 2021, Volume: 51, Issue:3

Topics: Aged; Anticoagulants; Arginine; Canada; Female; Fondaparinux; Gastrointestinal Neoplasms; Hematologic Neoplasms; Hemorrhage; Heparin; Humans; Male; Patient Acuity; Pipecolic Acids; Platelet Count; Retrospective Studies; Risk Adjustment; Sulfonamides; Thrombocytopenia

2021